News

Secondary Cancers Resurface in Lenalidomide Maintenance Trial Data

Publish date: May 6, 2011

 

This coverage is provided courtesy of "The Pink Sheet." "The Pink Sheet" and Internal Medicine News Digital Network are both owned by Elsevier.

Pages

Recommended Reading

Rare Lymphoma Reports Continue in Young Patients on TNF Blockers
MDedge Hematology and Oncology
Gynecologic Cancer Symptoms May Be More Severe in Women With Psychiatric Histories
MDedge Hematology and Oncology
Opioid Abuse Is Rising Concern in Cancer Patients and Survivors
MDedge Hematology and Oncology
Sequencing Reveals MAP3K1 Mutation in Luminal-Type Breast Cancer
MDedge Hematology and Oncology
Robotic Techniques Show Promise for Pancreatic Procedures
MDedge Hematology and Oncology
Wearable Electric Fields Device Approved for Brain Tumors
MDedge Hematology and Oncology
Early Results Promising for Robotic Pancreatic Resection
MDedge Hematology and Oncology
Lymphatic Invasion Predicts Recurrence in Merkel Cell Cancer
MDedge Hematology and Oncology
FDA Approves Abiraterone for Castration-Resistant Prostate Cancer
MDedge Hematology and Oncology
Radical Prostatectomy Continues to Cut Mortality After 15 Years
MDedge Hematology and Oncology